XML 57 R37.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed financial information of the parent company
12 Months Ended
Mar. 31, 2021
Condensed Financial Information Disclosure [Abstract]  
Condensed financial information of the parent company
 
31.
Condensed financial information of the parent company
The Company performed a test on the restricted net assets of consolidated subsidiaries in accordance with Securities and Exchange Commission
Regulation S-X
Rule 4-08
(e) (3), “General Notes to Financial Statements” and concluded that it was applicable for the Company to disclose the financial statements for the parent company.
The subsidiaries did not pay any dividends to the Company for the periods presented. For the purpose of presenting parent company only financial information, the Company records its investments in its subsidiaries under the equity method of accounting. Such investments are presented on the separate condensed balance sheets of the Company as “Investments (deficit) in subsidiaries” and the loss of the subsidiaries is presented as “share of losses of subsidiaries”. Certain information and footnote disclosures generally included in financial statements prepared in accordance with US GAAP have been condensed and omitted. The footnote disclosures contain supplemental information relating to the operations of the Company, as such, these statements should be read in conjunction with the notes to the consolidated financial statements of the Company.
The parent company did not have significant capital and other commitments, long-term obligations, other long-term debt, or guarantees as of March 31, 2020 and 2021.
 
Balance sheets
 
   
As of March 31,
   
As of March 31,
 
   
2020
   
2021
 
   
RMB
   
RMB
   
US$
(Note 2(f))
 
ASSETS
      
Current assets:
      
Cash and cash equivalents
   1,145    18,285    2,791 
Prepayments and other current assets
   686,819    1,208,128    184,396 
  
 
 
   
 
 
   
 
 
 
Total current assets
   687,964    1,226,413    187,187 
  
 
 
   
 
 
   
 
 
 
Non-current
assets:
      
Other
non-current
asset
   7,943    344    53 
  
 
 
   
 
 
   
 
 
 
Total
non-current
assets
   7,943    344    53 
  
 
 
   
 
 
   
 
 
 
Total assets
   695,907    1,226,757    187,240 
  
 
 
   
 
 
   
 
 
 
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ DEFICIT
      
Current liabilities
      
Short-term borrowings
   42,485    —      —   
Accrued liabilities and other current liabilities
   12,126    5,017    766 
Other debts, current
   76,252    —      —   
Derivative liabilities
   14,816    444    68 
  
 
 
   
 
 
   
 
 
 
Total current liabilities
   145,679    5,461    834 
  
 
 
   
 
 
   
 
 
 
Non-current
liabilities:
      
Long-term borrowings
   4,957    —      —   
Negative carrying amount of subsidiaries
   690,121    1,138,622    173,788 
  
 
 
   
 
 
   
 
 
 
Total
non-current
liabilities
   695,078    1,138,622    173,788 
  
 
 
   
 
 
   
 
 
 
Total liabilities
   840,757    1,144,083    174,622 
  
 
 
   
 
 
   
 
 
 
Mezzanine equity:
      
Series A convertible redeemable preferred shares (US$ 0.001 par value; 11,000,000 shares authorized, 10,340,000 and nil shares issued and outstanding as of March 31, 2020 and 2021, respectively)
   484,122    —      —   
Series B convertible redeemable preferred shares (US$ 0.001 par value; 10,000,000 shares authorized, 9,067,384 and nil shares issued and outstanding as of March 31, 2020 and 2021, respectively)
   527,682    —      —   
Series C convertible redeemable preferred shares (US$ 0.001 par value; 6,000,000 shares authorized, 5,518,101 and nil shares issued and outstanding as of March 31, 2020 and 2021, respectively)
   420,419    —      —   
Series D convertible redeemable preferred shares (US$ 0.001 par value; 3,000,000 shares authorized, 2,526,026 and nil shares issued and outstanding as of March 31, 2020 and 2021, respectively)
   188,183    —      —   
Series
D-1
convertible redeemable preferred shares (US$ 0.001 par value; 3,000,000 shares authorized, 2,178,530 and nil shares issued and outstanding as of March 31, 2020 and 2021, respectively)
   164,282    —      —   
Series
D-2
convertible redeemable preferred shares (US$ 0.00001 par value; 2,000,000 shares authorized, 1,182,803 and nil shares issued and outstanding as of March 31, 2020 and 2021, respectively)
   89,464    —      —   
Series E convertible redeemable preferred shares (US$ 0.001 par value; 3,000,000 and 7,000,000 shares authorized, 1,042,623 and nil shares issued and outstanding as of March 31, 2020 and 2021, respectively)
   78,553    —      —   
Receivable for issuance of preferred shares
   (94,758   —      —   
  
 
 
   
 
 
   
 
 
 
Total mezzanine equity
   1,857,947    —      —   
  
 
 
   
 
 
   
 
 
 
 
   
As of March 31,
 
   
2020
   
2021
 
   
RMB
   
RMB
   
US$
(Note 2(f))
 
Stockholders’ deficit:
      
Ordinary Shares (US$0.001 par value;153,000,000 ordinary shares authorized and 22,238,454 issued and outstanding as of March 31, 2020; nil shares issued and outstanding as of March 31, 2021)
   139    —      —   
Class A ordinary shares (US$0.001 par value; nil shares authorized, issued and outstanding shares as of March 31, 2020; 129,500,000 shares authorized, 54,505,108 shares issued and outstanding as of March 31, 2021)
   —      364    56 
Class B ordinary shares (US$0.001 par value; nil shares authorized, issued and outstanding shares as of March 31, 2020; 15,000,000 shares authorized, 13,037,729 shares issued and outstanding as of March 31, 2021)
   —      82    12 
Statutory reserves
   2,627    3,047    465 
Additional
paid-in
capital
   —      3,272,612    499,498 
Accumulated other comprehensive loss
   11,204    (20,172   (3,079
Accumulated deficit
   (2,016,758   (2,759,882   (421,240
Receivable for issuance of ordinary shares
   (9   (413,377   (63,094
  
 
 
   
 
 
   
 
 
 
Total shareholders’ deficit
   (2,002,797   82,674    12,618 
  
 
 
   
 
 
   
 
 
 
Total liabilities, mezzanine equity and shareholders’ deficit
   695,907    1,226,757    187,240 
  
 
 
   
 
 
   
 
 
 
Statements of comprehensive loss
 
   
Year Ended March 31,
 
   
2019
   
2020
   
2021
 
   
RMB
   
RMB
   
RMB
   
US$
(Note 2(f))
 
Sales and marketing expenses
   —      —      (12,875   (1,965
General and administrative expenses
   (812   (4,631   (14,050   (2,144
  
 
 
   
 
 
   
 
 
   
 
 
 
Total operating expenses
   (812   (4,631   (26,925   (4,109
  
 
 
   
 
 
   
 
 
   
 
 
 
Loss from operations
   (812   (4,631   (26,925   (4,109
  
 
 
   
 
 
   
 
 
   
 
 
 
Interest income
   —      —      15,416    2,353 
Interest expense
   (5,624   (12,578   —      —   
Share of losses of subsidiaries
   (225,531   (134,660   (191,458   (29,221
Other (expense)/income, net
   —      (40,500   (3,008   (459
Fair value change of derivative liabilities
   (2,274   13,345    11,531    1,760 
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss attributable to Boqii Holding Limited
   (234,241   (179,024   (194,444   (29,676
  
 
 
   
 
 
   
 
 
   
 
 
 
Less: Accretion on the Preferred Shares to redemption value
   (392,550   (204,796   120,873    18,449 
Less: Accretion on redeemable
non-controlling
interests to redemption value
   —      —      (138   (21
Less: Deemed contribution from preferred shareholders
   (723   (1,142   (12,547   (1,915
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss attributable to Boqii Holding Limited’s ordinary shareholders
   (627,514   (384,962   (86,256   (13,163
  
 
 
   
 
 
   
 
 
   
 
 
 
Net loss
   (234,241   (179,024   (194,444   (29,676
Other comprehensive loss:
        
Foreign currency translation adjustment, net of nil tax
   3,808    2,021    (32,148   (4,907
Unrealized securities holding gains
   1,711    3,209    772    118 
  
 
 
   
 
 
   
 
 
   
 
 
 
Total comprehensive loss
   (228,722   (173,794   (225,820   (34,465
  
 
 
   
 
 
   
 
 
   
 
 
 
 
Statements of cash flows
 
  
 
Year Ended March 31,
 
  
 
2019
 
  
 
2020
 
  
 
2021
 
  
 
RMB
 
  
 
RMB
 
  
 
RMB
 
  
 

 
US$

(Note 2(f))
 

 
Net cash used in operating activities
   —      —      (47,806   (7,297
Net cash used in investing activities
   (99,221   (184,354   (588,953   (89,892
Net cash provided by financing activities
   81,206    155,712    660,366    100,792 
Effects of foreign exchange rate changes on cash and cash equivalents
   18,010    29,778    (6,465   (987
  
 
 
   
 
 
   
 
 
   
 
 
 
Net increase (decrease) in cash and cash equivalents
   (5   1,136    17,140    2,616 
Cash and cash equivalents at beginning of the year
   14    9    1,145    175 
  
 
 
   
 
 
   
 
 
   
 
 
 
Cash and cash equivalents at end of the year
   9    1,145    18,285    2,791